S.J. Enna is in people’s heads—in more ways than one. As a researcher, he has become an expert in defining the properties of GABA receptors, and has conducted research on other neurotransmitter receptors, their regulation, and their responses to psychotherapeutics, as well. Thus, he’s into people’s brains from the drug side of the pharmacy counter, making them less depressed, more attentive, and simply better able to cope with life.
Next, he’s growing students’ brains, as he serves as Professor of Molecular and Integrative Physiology, and Professor of Pharmacology, Toxicology, and Therapeutics at the University of Kansas Medical School. He has been so successful at this that he has received several awards, first at the University of Texas, where he taught on faculty for ten years, and then when he returned to his hometown to work and teach at the University of Kansas, where he chaired the department of Pharmacology, Toxicology, and Therapeutics for eleven years.
The third way in which Dr. Enna gets into people’s heads is through his words—or, more specifically, his publications. Between his voracious research and editorial efforts, Dr. Enna has contributed to hundreds of research and review articles, as well as over twenty books. He also serves as the editor of some major journals and other publications—including our very own Current Protocols in Pharmacology!
Because of the outstanding success of Dr. Enna’s career in research and education, and also because of his dedication to organizations such as ASPET, Wyeth (a renowned global pharmaceutical company) has awarded him the 2009 Torald Sollmann Award, to be presented on Sunday, April 18th. Dr. Enna’s award lecture, aptly title “Mentors, Methods, and Manuscripts,” will be delivered on Tuesday, April 21st.
See the ASPET Award Winners website for more information.

Gregory Petsko, an editor for Current Protocols Bioinformatics, presents the argument that in 40 years, we will see a significant increase in the number of neurological cases around the world. He states that we are facing an “…epidemic of neurological diseases on a global scale” and he feels that so far, the “…government has dropped the ball on this.”